Skip to main content
Livermore
Livermore
ZHEN

Private Advisor Group, LLC

SEC CIK
0001567755
Latest filing
Jul 27, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Private Advisor Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of TAK by Private Advisor Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−26,488−100.0%Sold outHolders
Q1 202626,488$490.5K<0.1%+3,892+17.2%AddedHolders
Q4 202522,596$352.3K<0.1%+1,277+6.0%AddedHolders
Q3 202521,319$312.1K<0.1%+21,319NewHolders
Q4 20240$00.0%−12,247−100.0%Sold outHolders
Q3 202412,247$174.2K<0.1%+520+4.4%AddedHolders
Q2 202411,727$151.8K<0.1%−847−6.7%ReducedHolders
Q1 202412,574$174.7K<0.1%−6,037−32.4%ReducedHolders
Q4 202318,611$265.6K<0.1%−443−2.3%ReducedHolders
Q3 202319,054$294.8K<0.1%+2,254+13.4%AddedHolders
Q2 202316,800$259.3K<0.1%+16,800NewHolders
Q1 20230$00.0%−10,629−100.0%Sold outHolders
Q4 202210,629$166<0.1%+41+0.4%AddedHolders
Q3 202210,588$137.0K<0.1%−159,479−93.8%ReducedHolders
Q2 2022170,067$2.39M<0.1%+35,385+26.3%AddedHolders
Q1 2022134,682$1.93M<0.1%+42,439+46.0%AddedHolders
Q4 202192,243$1.26M<0.1%−28,604−23.7%ReducedHolders
Q3 2021120,847$1.98M<0.1%+74,973+163.4%AddedHolders
Q2 202145,874$772.0K<0.1%+11,745+34.4%AddedHolders
Q1 202134,129$623.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.